Your session is about to expire
← Back to Search
NRTX-1001 Neural Cell Therapy for Epilepsy
Study Summary
This trial is testing whether a single administration of inhibitory nerve cells into the brain of subjects with drug-resistant epilepsy is safe and effective.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your MRI shows a possible cancerous growth.I have been on a stable dose of my seizure medication for at least a month.I have had an average of 2 or more seizures every month for the last 6 months.My epilepsy is caused by a progressive neurological condition.I still have seizures despite trying at least 2 different seizure medications.I have focal seizures known as temporal lobe epilepsy.You tried to harm yourself in the last year.You have another medical condition that would make it unsafe for you to take part in the study.I am between 18 and 65 years old.My seizures originate from a part of my brain that doesn't affect speech, or if they do, my memory test scores are low.You have serious mental health issues.I have a condition that weakens my immune system.My seizures are confirmed to originate from one side of my brain.You have a device in your head that stays there for a long time.
- Group 1: NRTX-1001 (Stage 1)
- Group 2: NRTX-1001 (Stage 2)
- Group 3: Sham Comparator (Stage 2)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this medical trial open to participants of all ages, including those over 35?
"According to the trial conditions, only individuals aged 18-55 will be considered for inclusion."
What are the criteria for entering this clinical trial?
"To be considered for the trial, potential participants must show evidence of aura and their age should lie between 18 to 55. Up to 40 people will be selected in total."
How many participants are allotted to this clinical experiment?
"To satisfy the requirements of this trial, 40 qualified participants are required. Those who wish to partake can do so at either Stanford University in Palo Alto or Oregon Health and Science University in Portland."
Are there multiple sites in Canada conducting this experiment?
"Currently, 8 clinical trial sites are hosting this research. Locations include Palo Alto, Portland and Chicago as well as 5 additional cities. If a participant is accepted into the study, it is advised to choose the closest site in order to ease travel requirements."
Are there any vacant slots available in this research trial?
"Affirmative, the information presented on clinicaltrials.gov attests that this investigation is still in search of participants. It was initially published on June 16th 2022 and has been modified most recently on September 26th 2022. 40 volunteers are required to be enrolled from 8 different venues."
Share this study with friends
Copy Link
Messenger